Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Rosalia G Blanco
Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation
Arrhythmias and sudden death Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation Abstract Objective Non-vitamin K oral anticoagulants (NOACs) require dose adjustment for renal function. We sought to investigate change in renal function over time in patients with atrial fibrillation (AF) and whether those on NOACs have appropriate dose adjustments according to its decline.
Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation
Arrhythmias and sudden death Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation http://orcid.org/0000-0002-7889-2083Taku Inohara1,2, DaJuanicia N Holmes2, Karen Pieper2, Rosalia G Blanco2, Larry A Allen3, Gregg C Fonarow4, Bernard J Gersh5, Elaine M Hylek6, Michael D Ezekowitz7,8, Peter R Kowey7,8, James A Reiffel9, Gerald V Naccarelli10, Paul S Chan11, Kenneth W Mahaffey12, Daniel E Singer13, James V Freeman14,...
Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation
Arrhythmias and sudden death Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation Taku Inohara1,2, DaJuanicia N Holmes2, Karen Pieper2, Rosalia G Blanco2, Larry A Allen3, Gregg C Fonarow4, Bernard J Gersh5, Elaine M Hylek6, Michael D Ezekowitz7,8, Peter R Kowey7,8, James A Reiffel9, Gerald V Naccarelli10, Paul S Chan11, Kenneth W Mahaffey12, Daniel E Singer13, James V Freeman14, Benjamin A Steinberg15, Eric D Peterson2, Jonathan P Piccini2...
B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation
Arrhythmias and sudden death Original research article B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation Taku Inohara1, Sunghee Kim1, Karen Pieper1, Rosalia G Blanco1, Larry A Allen2, Gregg C Fonarow3, Bernard J Gersh4, Michael D Ezekowitz5, Peter R Kowey5, James A Reiffel6, Gerald V Naccarelli7, Paul S Chan8, Kenneth W Mahaffey9, Daniel E Singer10, James V Freeman11, Benjamin A Steinberg12, Eric D Peterson1, Jonathan P Piccini1 on behalf of the...
B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation
Arrhythmias and sudden death Original research article B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation Taku Inohara1, Sunghee Kim1, Karen Pieper1, Rosalia G Blanco1, Larry A Allen2, Gregg C Fonarow3, Bernard J Gersh4, Michael D Ezekowitz5, Peter R Kowey5, James A Reiffel6, Gerald V Naccarelli7, Paul S Chan8, Kenneth W Mahaffey9, Daniel E Singer10, James V Freeman11, Benjamin A Steinberg12, Eric D Peterson1, Jonathan P Piccini1 on behalf of the...
Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation
Objective Chronic obstructive pulmonary disease (COPD) is associated with the development of atrial fibrillation (AF), and may complicate treatment of AF. We examined the association between COPD and symptoms, quality of life (QoL), treatment and outcomes among patients with AF.
B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation
Methods We evaluated the association between BNP levels and outcomes, including AF progression, composite outcome of major adverse cardiovascular or neurological events (MACNE) and major bleeding, via pooled logistic regression and Cox frailty models in Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II registry. AF progression was defined as either paroxysmal becoming persistent or permanent, or persistent becoming permanent at any follow-up.
Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation
Objective Chronic obstructive pulmonary disease (COPD) is associated with the development of atrial fibrillation (AF), and may complicate treatment of AF. We examined the association between COPD and symptoms, quality of life (QoL), treatment and outcomes among patients with AF.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Rosalia G
Contact Rosalia G, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack